• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.87% Nasdaq Up0.34%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    18.46 Down 0.46(2.43%) 4:00PM EST
    |After Hours : 18.07 Down 0.39 (2.11%) 5:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 1,101   592   416   620  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,101   592   416   620  
    Operating Expenses
    Research Development26,186  24,099  27,070  17,804  
    Selling General and Administrative5,004  4,787  4,582  4,677  
    Non Recurring -   -   -   -  
    Others253  254  253  253  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,342) (28,548) (31,489) (22,114)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,261  274  1,586  137  
    Earnings Before Interest And Taxes(28,081)(28,274)(29,903)(21,977)
    Interest Expense -   -   -  85  
    Income Before Tax(28,081)(28,274)(29,903)(22,062)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(28,081)(28,274)(29,903)(22,062)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (28,081) (28,274) (29,903) (22,062)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (28,081) (28,274) (29,903) (22,062)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.